OWKIN Annual Revenue, Number of Employees, Growth and Funding

Claim your profile

Overview

Location:
Total Funding:$11M
Industry:Biotech
Founded:2016
Lead Investor(s):F-Prime Capital, Eight Roads Ventures
Press
Claim your profile

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • OWKIN's estimated annual revenue is currently $17.5M per year.
  • OWKIN received $Undisclosed in venture funding in March 2019.
  • OWKIN's estimated revenue per employee is $155,000
  • OWKIN's total funding is $11M.

Employee Data

  • OWKIN has 113 Employees.
  • OWKIN grew their employee count by 28% last year.
  • OWKIN currently has 1 job openings.

Executive Contacts

NameTitle
Thomas ClozelCo-Founder & CEO
Gilles WainribCo-Founder & CSO
Annaaa BondarenkoCOO/CFO
Anna Huyghues-DespointesHead of Strategy
Meriem SeftaHEAD OF PARTNERSHIPS
Cedric WhitneyPARTNERSHIP MANAGER
Alicia SimionOffice Manager
Mikhail ZaslavskiyCRO
Pierre CourtiolCHIEF DATA SCIENTIST
Camille MariniVP, ENGINEERING

OWKIN was co-founded in 2016 by Thomas Clozel, MD, a clinical research doctor and former assistant professor in clinical hematology and Gilles Wainrib, PhD, a pioneer in the field of Artificial Intelligence in biology. OWKIN is an AI startup that uses machine learning to augment medical and biology research. Our proprietary platform, OWKIN Socrates, uses machine learning technology to integrate biomedical images, genomics and clinical data to discover biomarkers and mechanisms associated with diseases and treatment outcomes. Our team is international, multidisciplinary with incredible talent in machine learning, medicine and business. Our data scientists are among the best in the world, with several Kaggle Masters (top global 100), a DREAM Challenge top performer, and publications in ICML, NIPS and other top scientific journals. OWKIN develops scientific collaborations with top-tier medical institutions such as Mount Sinai, Inserm, Institut Curie and the Léon Bérard Center, and partners with leading pharmaceutical companies, including Amgen, Roche, and Ipsen. OWKIN has developed a state-of-the-art federated learning technology in healthcare to overcome the data sharing problem, building collective intelligence from distributed data at scale while preserving data privacy and security.

keywords:N/A

113

Number of Employees

$17.5M

Revenue (est)

1

Current Jobs

28%

Employee Growth %

$11M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
North Central B...
$41.2M2665%N/A
Axsome Therapeu...
$4.8M330%N/A
Progenics Pharm...
$20M12915%N/A
Sartorius Stedi...
$16.7M10826%N/A
Outlook Therape...
$6.8M44100%N/A
Prevail Therape...
$8.5M5596%N/A
Trudeau Institu...
$12.1M7811%N/A
Ichor Therapeut...
$5.6M3620%N/A
Ovid Therapeuti...
$9.6M625%N/A
SpringWorks The...
$9.1M59119%N/A

OWKIN News

09/03/2019 - Artificial Intelligence in Medical Imaging Market Is Thriving ...

... Voxel Technology, Renalytix AI plc, Beijing Pushing Technology Co. Ltd., PAIGE, mPulse Mobile, Suki AI Inc., BERG LLC, Zealth Inc., OWKIN ...

03/07/2019 - Owkin Closes A New Venture Round Led By F-Prime Capital ...

NEW YORK, March 07, 2019 (GLOBE NEWSWIRE) -- Owkin, a company which builds machine learning technologies and infrastructure to ...

12/13/2018 - OWKIN initiates AI research network made up of 44 ...

OWKIN, a New York City-based company that provides machine learning tools for medical research purposes, has launched an AI-powered ...

OWKIN Funding

DateAmountRoundLead InvestorsReference
2018-01-17$11.0MAOtium VentureArticle
2018-05-24$UndisclosedAGVArticle
2019-03-08$UndisclosedUndisclosedF-Prime CapitalArticle